IL6 and cancer: By targeting key signaling pathways such as IL-6/STAT3, autophagy, glycolysis, and Wnt/β-catenin, as well as by modulating the tumor microenvironment, ginsenosides enhance the efficacy of chemotherapy drugs in cancer types that exhibit resistance, including breast, lung, pancreatic cancers, and glioblastoma.